GLP-1 'Agonorexia' and Psychotic Disorders Rising in Young People

News roundup includes updates on plant-based psychoactive therapies, dissociative identity disorder, and the impact of antidepressants on traumatic brain injury

Published on Feb. 4, 2026

Got story updates? Submit your updates here. ›

This news roundup covers a variety of mental health topics, including the rise of 'agonorexia' linked to GLP-1 receptor agonist use, the potential for ibogaine as a regulated medical therapy in Colorado, living with dissociative identity disorder, and an increase in psychotic disorder diagnoses among younger populations in Ontario, Canada. The report also touches on the impact of serotonergic antidepressants on traumatic brain injury outcomes, delays in California's new psychiatric staffing rules, and the mixed effects of pink noise on sleep and mood.

Why it matters

These stories highlight emerging trends and challenges in the mental health field, from disordered eating behaviors associated with certain medications to the growing prevalence of psychotic disorders among younger generations. Understanding these developments can inform treatment approaches, public health policies, and efforts to destigmatize mental health conditions.

The details

The news roundup covers a range of mental health-related topics, including the rise of 'agonorexia' linked to the use of GLP-1 receptor agonists, Colorado's potential to become the first state to regulate the use of the plant-based psychoactive compound ibogaine as medical therapy, and insights into living with dissociative identity disorder. It also reports on data suggesting an increase in the incidence and proportion of psychotic disorder diagnoses, with a decrease in the age at diagnosis, in Ontario, Canada. Additionally, the roundup discusses a study finding no increased risk of adverse outcomes for those taking serotonergic antidepressants at the time of a traumatic brain injury, as well as delays in California's new emergency staffing rules for acute psychiatric hospitals. The report also covers the mixed effects of pink noise on sleep and mood, the launch of a new online mental health platform, and updates on efforts to combat drug addiction and substance abuse.

  • The news roundup covers developments from 2019 to 2026.

The players

Ronald C. Kessler

A psychiatric epidemiologist at Harvard Medical School in Boston, known as the world's most published in his field.

Got photos? Submit your photos here. ›

The takeaway

This news roundup highlights the evolving landscape of mental health, from emerging trends in disordered eating and psychotic disorders to the exploration of alternative therapies and the ongoing efforts to improve access to mental health resources and support. These developments underscore the importance of continued research, policy changes, and public awareness to address the growing mental health needs of individuals and communities.